{
    "clinical_study": {
        "@rank": "3305", 
        "arm_group": {
            "arm_group_label": "Gestational diabetes", 
            "description": "Primary cohort is women with diagnosis of gestational diabetes without evidence of overt diabetes"
        }, 
        "biospec_descr": {
            "textblock": "Serum for measurements of insulin, markers of inflammation"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "This is an observation study of women with gestational diabetes.  Subjects recruited undergo\n      immediate postpartum diabetic screening prior to discharge.  Post-partum screening for overt\n      diabetes is repeated 6-12 weeks postpartum.  The outcome of interest is the utility of an\n      immediate post partum screen for overt diabetes compared to a  traditional 6 week test."
        }, 
        "brief_title": "Oral Glucose Tolerance Testing After Gestational Diabetes", 
        "condition": [
            "Gestational Diabetes", 
            "Pregnancy", 
            "Obesity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Obesity", 
                "Diabetes, Gestational"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Singleton pregnancy\n\n          -  Gestational diabetes\n\n        Exclusion Criteria:\n\n          -  Multiple gestations\n\n          -  pre-pregnancy diabetes"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Primary cohort is obtained from a pregnant population at two academic medical centers."
            }
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02082301", 
            "org_study_id": "MH-IRB12-00581"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 6, 2014", 
        "location": [
            {
                "contact": {
                    "email": "pcatalano@metrohealth.org", 
                    "last_name": "Patrick Catalano, MD", 
                    "phone": "216-778-8462"
                }, 
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44109"
                    }, 
                    "name": "MetroHealth Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Honor Wolfe, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44106"
                    }, 
                    "name": "University Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Oral Glucose Tolerance Testing After Gestational Diabetes", 
        "overall_contact": {
            "email": "tedwatersmd@gmail.com", 
            "last_name": "Thaddeus Waters, MD", 
            "phone": "708-21-5459"
        }, 
        "overall_contact_backup": {
            "email": "pcatalano@matrohealth.org", 
            "last_name": "Patrick Catalano, MD", 
            "phone": "216-778-4262"
        }, 
        "overall_official": {
            "affiliation": "Loyola University", 
            "last_name": "Thaddeus Waters, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "2 hour fasting 75g OGTT immediately post partum.  This is compared to a traditional 6 week post partum 75g OGTT for the sensitivity, positive and negative predictive value of the immediate post partum test", 
            "measure": "Primary outcome: sensitivity of immediate post partum screen", 
            "safety_issue": "No", 
            "time_frame": "Immediate post partum"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02082301"
        }, 
        "responsible_party": {
            "investigator_affiliation": "MetroHealth Medical Center", 
            "investigator_full_name": "Ted Waters", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "A small sub-cohort of women will undergo an additional 2 hour fasting 75g OGTT in the third trimester with measurements of insulin, cytokines, lipids.", 
            "measure": "Secondary outcome: physiology", 
            "safety_issue": "No", 
            "time_frame": "3 time points: antepatum, immediate postpartum, 6 weeks post partum"
        }, 
        "source": "MetroHealth Medical Center", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Centers for Disease Control and Prevention", 
                    "agency_class": "U.S. Fed"
                }, 
                {
                    "agency": "Loyola University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "MetroHealth Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}